While eyelash extensions are trending, are they worth getting? Experts have revealed the adhesive in these artificial eyelashes may pose&nbsp;serious health risks&nbsp;for our eyes.

While the purpose of our eyelashes is to protect the eyes from any airborne particles that may cause infections, these extensions are used to make them look thicker and longer for fashionable makeovers.&nbsp;

Eyelash extensions are individual fibres made from silk, hair from mink or horse, plastic, or nylon. They are attached to our lashes using an adhesive or glue, which can result in various issues.&nbsp;

<a href="https://www.wionews.com/trending/miracle-german-man-becomes-only-7th-person-to-be-cured-of-hiv-742117">Also Read |&nbsp;MIRACLE! German man becomes only 7th person to be cured of HIV</a>

According to one research, about 40 per cent of women reported having an allergic reaction to the glue and over 60 per cent reported keratoconjunctivitis, which is inflammation of both conjunctiva and cornea at the same time.

Furthermore, reports suggest that consumers were sold&nbsp;nail glue instead of the one meant for eyelashes, which&nbsp;has serious risks as it is much more potent.

Eyelash adhesives can also reportedly increase the risk of cancer.

One study found that 75 per cent&nbsp;of the 20 professional glues released formaldehyde, a cancer-causing chemical. Additionally,&nbsp;four of the 17 consumer glues also had the chemical. Notably, some of the glues did not mention formaldehyde in their ingredients.

The eyelash glue also contains preservatives which can result in conjunctivitis and conjunctival erosion, which can affect a person's&nbsp;eyesight and cause pain. In this condition, the epithelium, the cells on the cornea's surface, loosens from the layer below it.&nbsp;

Also Read |&nbsp;<a href="https://www.wionews.com/science/scientists-close-to-creating-one-and-done-anti-flu-vaccine-to-kill-future-pandemic-742447">Scientists close to creating 'one and done' anti-flu vaccine to kill future pandemic</a>

According to The Conversation, the most common issue&nbsp;caused by eyelash extensions is blepharitis -&nbsp;irritation or inflammation of the eyelids, due to the build-up of bacteria.

Additionally, poor hygiene conditions at salons can also cause lash mite infestation. Eyelash extension removal, even by professionals, can deteriorate the health of natural lashes.

Some people have also started using eyelash serums which contain prostaglandin. These serums are becoming increasingly&nbsp;popular as they claim to&nbsp;increase the thickness, length, and darkness of natural lashes. However, they can still pose health risks.

These serums can result in the loss of fat tissues around the eyes,&nbsp;making&nbsp;them&nbsp;look hollow and dark circles worse. They can also change the colour of the irises&nbsp;permanently.

(With inputs from agencies)

While eyelash extensions are trending, are they worth getting? Experts have revealed the adhesive in these artificial eyelashes may pose serious health risks for our eyes.

While eyelash extensions are trending, are they worth getting? Experts have revealed the adhesive in these artificial eyelashes may pose serious health risks for our eyes. While the purpose of our eyelashes is to protect the eyes from any airborne particles that may cause infections, these extensions are used to make them look thicker and longer for fashionable makeovers. Eyelash extensions are individual fibres made from silk, hair from mink or horse, plastic, or nylon. They are attached to our lashes using an adhesive or glue, which can result in various issues. Also Read | MIRACLE! German man becomes only 7th person to be cured of HIV According to one research, about 40 per cent of women reported having an allergic reaction to the glue and over 60 per cent reported keratoconjunctivitis, which is inflammation of both conjunctiva and cornea at the same time. Furthermore, reports suggest that consumers were sold nail glue instead of the one meant for eyelashes, which has serious risks as it is much more potent. Eyelash adhesives can also reportedly increase the risk of cancer. One study found that 75 per cent of the 20 professional glues released formaldehyde, a cancer-causing chemical. Additionally, four of the 17 consumer glues also had the chemical. Notably, some of the glues did not mention formaldehyde in their ingredients. The eyelash glue also contains preservatives which can result in conjunctivitis and conjunctival erosion, which can affect a person's eyesight and cause pain. In this condition, the epithelium, the cells on the cornea's surface, loosens from the layer below it. Also Read | Scientists close to creating 'one and done' anti-flu vaccine to kill future pandemic According to The Conversation, the most common issue caused by eyelash extensions is blepharitis - irritation or inflammation of the eyelids, due to the build-up of bacteria. Additionally, poor hygiene conditions at salons can also cause lash mite infestation. Eyelash extension removal, even by professionals, can deteriorate the health of natural lashes. Some people have also started using eyelash serums which contain prostaglandin. These serums are becoming increasingly popular as they claim to increase the thickness, length, and darkness of natural lashes. However, they can still pose health risks. These serums can result in the loss of fat tissues around the eyes, making them look hollow and dark circles worse. They can also change the colour of the irises permanently. (With inputs from agencies)

Eyelash extensions can pose serious health risks, warn experts

People who vape suffer similar changes to their DNA as smokers who develop cancer, researchers have revealed. Watch to know more.

A UK study finds vaping a health risk

The World Health Organization (WHO) on Tuesday (Dec 19) classified the JN.1 strain of COVID-19 as a "variant of interest" but added that it did not pose a major threat to public health. 
 
Previously, JN.1 was classified as a variant of interest under its parent lineage BA.2.86. "Based on the available evidence, the additional global public health risk posed by JN.1 is currently evaluated as low," said WHO. 
 
The organisation added that current vaccines will be able to protect people against severe disease and death from the new variant JN.1 as well as other circulating variants of COVID-19. 
 
The World Health Organization earlier said that the virus has been evolving and changing and appealed to the member states to continue sharing the sequence of virus spread and carry out strong surveillance.

Also read:&nbsp;<a href="https://www.wionews.com/india-news/india-new-concerning-covid-19-subvariant-jn1-detected-in-kerala-know-its-symptoms-669486">JN.1 in India and HV.1 in US, Covid doesn't seem to be giving us a break</a>

Taking to X, the WHO wrote, “Dr @mvankerkhove talks about the current surge in respiratory diseases #COVID19 and JN.1 subvariant. WHO continues to assess the situation. Follow WHO's public health advice to keep your families and friends safe during this holiday season.” 
 
Earlier this month, the US Centres for Disease Control and Prevention (CDC) said that the subvariant JN.1 has been found in an estimated 15 per cent to 29 per cent of cases in the United States till December 8, as per the latest projections of the agency. 
 
It said that currently, no evidence has proved that JN.1 can increase the risk to public health in comparison to other current variants which have been circulating and added that that an updated vaccine will be helpful in keeping Americans protected against the variant. 
 
According to the CDC, the variant of JN.1 was first detected in September in the United States. Last week, seven infections of the COVID subvariant were detected by China.

<h2>JN.1 variant in India</h2>

The JN.1 variant was also detected in the Indian state of Kerala which forced the government to issue an advisory to the state governments appealing them to make adequate health arrangements.

Watch:&nbsp;Covid-19 makes global comeback; new Omicron sub-variant JN.1 causes global concern&nbsp;

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/covid-19-makes-global-comeback-new-omicron-sub-variant-jn1-causes-global-concern-wion-671372/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

"Considering the upcoming festive season, there is a need to put in place requisite public health measures and other arrangements to minimise the risk of increase in transmission of the disease by adherence to the maintenance of respiratory hygiene,” read the advisory.

(With inputs from agencies)

The World Health Organization (WHO) on Tuesday (Dec 19) classified the JN.1 strain of COVID-19 as a "variant of interest" but added that it did not pose a major threat to public health.

The World Health Organization (WHO) on Tuesday (Dec 19) classified the JN.1 strain of COVID-19 as a "variant of interest" but added that it did not pose a major threat to public health. Previously, JN.1 was classified as a variant of interest under its parent lineage BA.2.86. "Based on the available evidence, the additional global public health risk posed by JN.1 is currently evaluated as low," said WHO. The organisation added that current vaccines will be able to protect people against severe disease and death from the new variant JN.1 as well as other circulating variants of COVID-19. The World Health Organization earlier said that the virus has been evolving and changing and appealed to the member states to continue sharing the sequence of virus spread and carry out strong surveillance. Also read: JN.1 in India and HV.1 in US, Covid doesn't seem to be giving us a break Taking to X, the WHO wrote, “Dr @mvankerkhove talks about the current surge in respiratory diseases #COVID19 and JN.1 subvariant. WHO continues to assess the situation. Follow WHO's public health advice to keep your families and friends safe during this holiday season.” Earlier this month, the US Centres for Disease Control and Prevention (CDC) said that the subvariant JN.1 has been found in an estimated 15 per cent to 29 per cent of cases in the United States till December 8, as per the latest projections of the agency. It said that currently, no evidence has proved that JN.1 can increase the risk to public health in comparison to other current variants which have been circulating and added that that an updated vaccine will be helpful in keeping Americans protected against the variant. According to the CDC, the variant of JN.1 was first detected in September in the United States. Last week, seven infections of the COVID subvariant were detected by China. JN.1 variant in India The JN.1 variant was also detected in the Indian state of Kerala which forced the government to issue an advisory to the state governments appealing them to make adequate health arrangements. Watch: Covid-19 makes global comeback; new Omicron sub-variant JN.1 causes global concern "Considering the upcoming festive season, there is a need to put in place requisite public health measures and other arrangements to minimise the risk of increase in transmission of the disease by adherence to the maintenance of respiratory hygiene,” read the advisory. (With inputs from agencies)

WHO labels JN.1 Covid strain as a ‘variant of interest’, says its health risk is low

health-risk

Health Risk, News on Health Risk, stories on Health Risk, articles on Health Risk, Health Risk stories at Wion, Health Risk news, Health Risk latest news